EUCTR2017-003627-30-DK进行中(未招募)1 期
Protection from food induced anaphylaxis by reducing serum level of specific IgE - Protana
Odense Research Center for Anaphylaxis (ORCA)0 个研究点目标入组 10 人开始时间: 2018年3月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •10 male or female subjects, age 18 - 70 years with verified allergy to a food allergen, where validated methods for determination of specific IgE to the food and to the major allergens (Component Resolved Diagnostics) are available. The foods include, but will not be confined to milk, egg, peanut, hazelnut, sesame, wheat, cod and shrimp. Patients with/without elevated levels of total IgE (> 1000 kIU/l) will be included. Minimum level of specific IgE to the major allergen component in the food in question will be 10 kIU/l. No control group will be included.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 9
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 1
排除标准
- •Ischemic heart disease or other significant co-morbidity (e.g. uncontrolled asthma) that might compromise the patient’s safety or study outcomes.
- •Infection on the day of study
- •Pregnancy or nursing
- •Ongoing treatment with antihistamine or drugs with antihistaminic properties that cannot be paused three days prior to the tests
- •Ongoing treatment with ß-blockers that cannot be paused one day prior to the tests
- •Ongoing treatment with oral glucocorticoids (>10 mg daily)
- •Alcohol abuse, abuse of opioids or other drugs
- •Occurrence of unexpected side effects
- •Patients who are not supposed to be able to meet the requirements in the protocol
- •Patients who are physically or mentally unable to consent
研究者
相似试验
终止
4 期
Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).Food AllergyNCT03964051Carsten Bindslev-Jensen7
进行中(未招募)
1 期
Treatment of severe peanut allergy with oral immunotherapy with peanuts during protection with anti-IgE antibodies, Xolair (omalizumab).EUCTR2012-005625-78-SEKarolinska Institutet23
招募中
不适用
Primary prevention of food allergy by restricting maternal intake of processed meat and others during first month after birthJPRN-UMIN000035585The Jikei University School of Medicine210
已完成
Unknown
Effects of consumption of the test food on allergic reaction of eyes and nose in healthy Japanese subjects: a randomized, placebo-controlled, double-blind, parallel-group comparison studyJPRN-UMIN000049377ORTHOMEDICO Inc.44
已完成
不适用
Effects on allergic reaction of eyes and nose in healthy Japanese subjectsHealthy Japanese subjectsJPRN-UMIN000048565ORTHOMEDICO Inc.10
